D. Akyüzlü Et Al. , "OPRM1 rs2075572 has potential to affect plasma buprenorphine level in opioid users, but not OPRM1 rs562859," NEUROSCIENCE LETTERS , vol.834, pp.137846, 2024
Akyüzlü, D. Et Al. 2024. OPRM1 rs2075572 has potential to affect plasma buprenorphine level in opioid users, but not OPRM1 rs562859. NEUROSCIENCE LETTERS , vol.834 , 137846.
Akyüzlü, D., Kotiloğlu, S. Ö., Danışman, M., & Bal, C., (2024). OPRM1 rs2075572 has potential to affect plasma buprenorphine level in opioid users, but not OPRM1 rs562859. NEUROSCIENCE LETTERS , vol.834, 137846.
Akyüzlü, DİLEK Et Al. "OPRM1 rs2075572 has potential to affect plasma buprenorphine level in opioid users, but not OPRM1 rs562859," NEUROSCIENCE LETTERS , vol.834, 137846, 2024
Akyüzlü, DİLEK Et Al. "OPRM1 rs2075572 has potential to affect plasma buprenorphine level in opioid users, but not OPRM1 rs562859." NEUROSCIENCE LETTERS , vol.834, pp.137846, 2024
Akyüzlü, D. Et Al. (2024) . "OPRM1 rs2075572 has potential to affect plasma buprenorphine level in opioid users, but not OPRM1 rs562859." NEUROSCIENCE LETTERS , vol.834, p.137846.
@article{article, author={DİLEK AKYÜZLÜ Et Al. }, title={OPRM1 rs2075572 has potential to affect plasma buprenorphine level in opioid users, but not OPRM1 rs562859}, journal={NEUROSCIENCE LETTERS}, year=2024, pages={137846} }